Rabeprazole: all 123 studies that test it
Page 2 of 2. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, InclusiveCompletedNCT00747695Phase 1
- A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, InclusiveCompletedNCT00747526Phase 1
- A Comparative Study of Proton-pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 GenotypesCompletedNCT00681005Not applicable
- Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mgCompletedNCT00649493Phase 1
- Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.CompletedNCT00553449Phase 3
- The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERDStatus unknownNCT00539786Not applicable
- A Study of the Use of High-dose Proton Pump Inhibitor for the Treatment of Gastro-oesophageal Reflux Related Non-cardiac Chest Pain - a Randomized Double-blind Placebo-controlled StudyStatus unknownNCT00517270Not applicable
- Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese PatientsCompletedNCT00517114Not applicable
- A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking PantoprazoleCompletedNCT00378287Phase 1
- CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor TestingCompletedNCT00354757Phase 4
- Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERDCompletedNCT00304421Phase 4
- Sleep Disorders and Gastroesophageal Reflux Disease (GERD)CompletedNCT00287391Phase 4
- A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime HeartburnCompletedNCT00237367Phase 4
- A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)CompletedNCT00236392Phase 3
- Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid SuppressionCompletedNCT00234117Not applicable
- Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)CompletedNCT00222170Phase 2
- Rabeprazole Protection of Aspirin Induced Gastric Damage.CompletedNCT00220857Phase 4
- A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)CompletedNCT00216489Phase 4
- Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.CompletedNCT00216450Phase 4
- Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.CompletedNCT00214552Phase 3
- Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) TreatmentCompletedNCT00204698Phase 2/3
- Post-nasal Drainage as an Extraesophageal Manifestation of RefluxCompletedNCT00199953Phase 2
- Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) InfectionStatus unknownNCT00197418Phase 2/3